These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20838028)

  • 1. Hepatoprotective effects of Sedum sarmentosum on D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure.
    Lian LH; Jin X; Wu YL; Cai XF; Lee JJ; Nan JX
    J Pharmacol Sci; 2010; 114(2):147-57. PubMed ID: 20838028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
    Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
    Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
    Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
    J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
    Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
    Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
    Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
    Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
    J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cordyceps sinensis prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Cheng YJ; Cheng SM; Teng YH; Shyu WC; Chen HL; Lee SD
    Am J Chin Med; 2014; 42(2):427-41. PubMed ID: 24707872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhetinic acid attenuates lipopolysaccharide-induced fulminant hepatic failure in d-galactosamine-sensitized mice by up-regulating expression of interleukin-1 receptor-associated kinase-M.
    Yin X; Gong X; Zhang L; Jiang R; Kuang G; Wang B; Chen X; Wan J
    Toxicol Appl Pharmacol; 2017 Apr; 320():8-16. PubMed ID: 28213090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice.
    Dong L; Yin L; Quan H; Chu Y; Lu J
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29057809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
    Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
    Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diterpenoid acanthoic acid from Acanthopanax koreanum protects against D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
    Nan JX; Jin XJ; Lian LH; Cai XF; Jiang YZ; Jin HR; Lee JJ
    Biol Pharm Bull; 2008 Apr; 31(4):738-42. PubMed ID: 18379074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
    Lee WC; Kim JK; Kang JW; Oh WY; Jung JY; Kim YS; Jung HA; Choi JS; Lee SM
    Food Chem Toxicol; 2010 Jan; 48(1):222-8. PubMed ID: 19818826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.
    Ma L; Gong X; Kuang G; Jiang R; Chen R; Wan J
    Biochem Biophys Res Commun; 2015 May; 461(2):230-6. PubMed ID: 25866179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betulinic acid prevention of d-galactosamine/lipopolysaccharide liver toxicity is triggered by activation of Bcl-2 and antioxidant mechanisms.
    Zheng ZW; Song SZ; Wu YL; Lian LH; Wan Y; Nan JX
    J Pharm Pharmacol; 2011 Apr; 63(4):572-8. PubMed ID: 21401610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-apoptotic activity of gentiopicroside in D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure.
    Lian LH; Wu YL; Wan Y; Li X; Xie WX; Nan JX
    Chem Biol Interact; 2010 Oct; 188(1):127-33. PubMed ID: 20558151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice.
    Yin X; Gong X; Jiang R; Kuang G; Wang B; Zhang L; Xu G; Wan J
    Int Immunopharmacol; 2014 Nov; 23(1):66-72. PubMed ID: 25173984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
    Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
    Tao YC; Wang ML; Wu DB; Luo C; Tang H; Chen EQ
    J Transl Med; 2019 May; 17(1):151. PubMed ID: 31077206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.